How to start and stay on RHAPSIDO® (remibrutinib)
Patient portrayal; pill not actual size.
Experience RHAPSIDO
RHAPSIDO is a first-of-its-kind† pill for chronic hives with no known external triggers.
†Treatment that targets inside the mast cell, helping to inhibit some histamine release.
Starting RHAPSIDO
RHAPSIDO is a twice-daily pill you can take anywhere, with or without food.
The recommended RHAPSIDO starting dose is 25 mg taken orally twice daily.
RHAPSIDO tablets should be swallowed whole with water, and should not be split, crushed, or chewed.
If a dose of RHAPSIDO is missed, it should be skipped, and the next dose should be taken at its regularly scheduled time. You should not take extra doses to make up for a missed dose or doses.
Staying on RHAPSIDO
Chronic hives with no known external triggers can last for a while. Your doctor will determine how long you should take RHAPSIDO. For RHAPSIDO to work the way it’s meant to, it’s important to continue taking it exactly as your doctor prescribed.
For full dosing information, download the RHAPSIDO Prescribing Information.
"I encourage people living with this condition to speak up about their needs. Ask questions and seek support."
– Lauren, a real patient living with CSU taking RHAPSIDO
Sharing your story can make a difference
If you or a loved one is taking RHAPSIDO, Novartis Pharmaceuticals Corporation invites you to share your personal journey through The Voices of Inspiration Network. The Voices of Inspiration Network is a voluntary program of patient and caregiver advocates who share their experiences to help and inspire others. By joining Voices of Inspiration, you may have the opportunity to speak publicly about your experiences and may be compensated for your time.
Activities of a RHAPSIDO Ambassador may include, but are not limited to, videos, photography, and public speaking. An honorarium may be provided to participants as compensation for their time. For additional details, please call 1-877-879-0245. Must be 18 years of age or older to self-nominate. The individual must currently be taking, or be the caregiver to someone currently taking, RHAPSIDO in accordance with U.S. Food and Drug Administration (FDA) approved use, and be willing to share their personal journey to be used for promotional or marketing purposes.
Ready to share your story?
Call us at 1-877-879-0245 or email us your story at [email protected].